Standards & Regulation

With big regulatory changes on the horizon, RAPS invests in Europe.

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

We Sit Down With Daniel O'Connor, Medical Assessor at the MHRA, UK.

Hygiene is essential to pharma, but there are a suprising number of ways it can go wrong.

New patient adherence tablet app incorporates storytelling and patient data.

Bribery accusations, a new whistleblowing policy, and recalls... What’s new for pharma in business?

How does the FBI track down culprits of pharma heists?

India has held pharma’s interest for decades, but it is a challening market to work in.

FDA and EMA forge an agreement to mutually recognize drug manufacturing inspections.

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far